About this trial
The goal of this study is to learn whether NeuroEyeCoach, a computer-based eye movement training programme, can help stroke survivors with visual field loss. The study will also assess whether a larger clinical trial is feasible. The main questions it aims to answer are:
* Can stroke survivors be successfully recruited, randomised and followed up in a larger trial? * Is NeuroEyeCoach acceptable and practical to use? * Is there early evidence that NeuroEyeCoach improves vision-related functioning and wellbeing? Researchers will compare NeuroEyeCoach plus usual care with usual care alone.
Participants will:
* Be randomly assigned to receive NeuroEyeCoach plus usual care or usual care alone * Complete six weeks of training if allocated to NeuroEyeCoach * Complete questionnaires and tests of vision, daily activities, quality of life, confidence and wellbeing * Take part in follow-up assessments over six months This pilot trial will include 60 stroke survivors living with visual field loss after stroke. Findings will be used to inform the design of a larger study.
Eligibility criteria
Qualifiers
adult (>18 years)
stroke survivor
stroke-related homonymous VFL (minimum quadrantanopia)
sufficient language, cognitive, and upper limb ability to participate in trial activities.
Disqualifiers
pre-existing (ie pre-stroke) registration as sight impaired (partially sighted) or severely sight impaired (blind)
• history of seizure disorders, especially those of a photosensitive nature
Trial design
Treatments tested in this trial
- NeuroEyeCoach eye movement training
- Usual Care
Treatment groups
Locations
Sponsors and collaborators
Glasgow Caledonian University
Lead sponsor
National Health Service, United Kingdom
Collaborator